Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001641172-25-017072
Filing Date
2025-06-30
Accepted
2025-06-30 09:39:52
Documents
1
Period of Report
2025-06-26

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3722
  Complete submission text file 0001641172-25-017072.txt   5392
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Issuer) CIK: 0001213037 (see all company filings)

EIN.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 9220 KIRBY DRIVE SUITE 500 HOUSTON TX 77054
Business Address
TANNENBAUM RENEE P (Reporting) CIK: 0001543174 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35558 | Film No.: 251089021